ArticleResearch square2026
Large-scale antibody reactome profiling identifies herpesvirus-autoantigen associations underlying chronic diseases.
Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
Abstract
Herpesviruses infect nearly all humans and have long been implicated in autoimmune and chronic diseases, yet their immune interactions with host proteins have not been systematically characterized at population scale. We profiled immunoglobulin G reactivities to >4,600 herpesvirus peptides and >15,000 human proteins using multiplexed protein display in two Mass General Brigham Biobank cohorts (discovery n=1,289; replication n=763), with longitudinal electronic health record follow-up. We identified and replicated 3,943 FDR-significant associations across 93 autoantigens, including previously uncharacterized viral-autoantigen axes, such as PHLDA1 and ZNF550. Eleven autoantigens were predicted by viral peptide reactivities with >85% accuracy in independent validation; some exhibited shared viral-host sequence homology, consistent with possible molecular mimicry. Integrating immune reactivities with incident disease outcomes revealed virus-specific network architectures: cytomegalovirus formed the largest multimorbid network, Epstein-Barr virus converged on pleiotropic autoimmune hubs, and herpes simplex viruses formed smaller, partially overlapping autoreactive networks. These findings define a herpesvirus-autoantigen-disease network atlas and prioritize candidate viral-host immune axes for mechanistic investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.